Tags |
|
|
Links |
|
|
Main Subject - S-Corporations State and Tax Issues
More than a few people prefer to form corporations to protect their businesses, but look for a more favorable tax situatio
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
n. The answer, of course, is the S-corporation.
For a long time, corporations were the dominant business entity availabl
For a long time, corporations were the dominant business entity availabl
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
e to most business. With their rigid rules protecting shareholders from personal liability for the debts of the business,
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
they were a smart and popular choice. The downside of the corporate entity, however, had to do with taxes. Simply put, a d
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ouble taxation situation arose because the corporation had to pay taxes on its profits and then the shareholders had to al
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
so pay taxes on their dividends and earnings.
The IRS eventually got around to dealing with the double taxation issue. We
The IRS eventually got around to dealing with the double taxation issue. We
ucts have become life saving products for the pharmaceutical companies who doesnt have many innovative molecules in their product pipeline and have been inc
ll, Congress did. Instead of changing how the corporation was taxed, Congress enacted Subchapter S of the internal revenue
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
code. This section, of course, lends its title to the name of the S corporation.
The goal with the new tax code sectio
The goal with the new tax code sectio
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
n was to give small business a break when they used corporations. Instead of dealing with double taxation issues, small bu
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
sinesses could elect to be treated differently. By electing to be an S-corporation, they could pass through the finances o
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
f the business to their personal tax returns much like a partnership. This is not a tax article per se, so the important t
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
hing to understand is the tax burden is less with the S election.
In passing the code, Congress also limited the situatio
In passing the code, Congress also limited the situatio
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ns in which it could be used. The restrictions are fairly basic. You can have no more than 75 shareholders. The shareholde
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
rs can be individuals, but not LLCs or C corporations. Congress also required you to show your cards early on your designa
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
tion. You have 2 months and 15 days from formation to declare your S status by filing form 2553 with the IRS.
You will no
You will no
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
te from the above discussion, there is no mention of states. This is because the S corporation is purely a federal tax iss
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ue. Many states do not even recognize that S corps exist for tax purposes, meaning they tax it exactly like a C corporatio
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
n. Obviously, you will have to check your states view on the matter.
Regardless, the important thing to tax from this art
Regardless, the important thing to tax from this art
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
icle is the S-corporation is largely a tax issue on the federal level. When it comes to forming the entity in your state,
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
you just file the basic corporation papers required by your secretary of state. The S election is then made with the IRS.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/1249/mainsubjects-SCorporations--State-and-Tax-Issues.html">S-Corporations State and Tax Issues</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/1249/mainsubjects-SCorporations--State-and-Tax-Issues.html]S-Corporations State and Tax Issues[/url]
Related Articles:
Should You Start A Business With A Friend?
What Can American Idol Teach You About Business?
Bookmark it:
|